Henry Schein scored a 100 on the 2023 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, Henry Schein increases the risk of dividing employees, alienating customers and harming shareholders. The company covers transgender-related medical costs for its employees and their children and provides specific sexual orientation and gender identity-based benefits. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Henry Schein forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. Henry Schein has supported the Equality Act and donated to GLMA: Health Professionals Advancing LGBTQ Equality, an LGBTQ advocacy group that opposed the overturn of Roe v. Wade and the prohibition of sex transition surgeries for children. For these reasons, Henry Schein receives a High Risk rating.